Ibritumomab Intravenous and Vancenase AQ
Determining the interaction of Ibritumomab Intravenous and Vancenase AQ and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: beclomethasone nasal
Brand name: Beconase AQ, QNASL, Beconase, Vancenase, Vancenase AQ, Vancenase AQ DS, QNASL
Synonyms: Vancenase AQ (Nasal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Vancenase AQ Double Strength
- Ibritumomab Intravenous-Vancocin
- Ibritumomab Intravenous-Vancocin HCl
- Ibritumomab Intravenous-Vancocin HCl Pulvules
- Ibritumomab Intravenous-Vancoled
- Ibritumomab Intravenous-Vancomycin
- Vancenase AQ-Ibritumomab Tiuxetan
- Vancenase AQ-Ibrutinib
- Vancenase AQ-Ibrutinib Capsules
- Vancenase AQ-Ibrutinib Tablets
- Vancenase AQ-Ibu
- Vancenase AQ-IBU Tablets